DENTSPLY SIRONA’s (XRAY) Outperform Rating Reaffirmed at Barrington Research

Barrington Research reaffirmed their outperform rating on shares of DENTSPLY SIRONA (NASDAQ:XRAY) in a report released on Tuesday,Benzinga reports. The firm currently has a $14.00 target price on the medical instruments supplier’s stock.

Several other analysts also recently issued reports on the company. Wall Street Zen downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Saturday, October 18th. Barclays began coverage on DENTSPLY SIRONA in a research report on Monday, December 8th. They set an “underweight” rating and a $12.00 target price for the company. Evercore ISI dropped their price target on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating on the stock in a research report on Wednesday, October 8th. Wells Fargo & Company reduced their price objective on shares of DENTSPLY SIRONA from $15.00 to $12.00 and set an “equal weight” rating for the company in a research note on Friday, November 7th. Finally, Stifel Nicolaus set a $13.00 target price on shares of DENTSPLY SIRONA in a research note on Thursday, November 6th. Two analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of “Reduce” and a consensus price target of $15.15.

DENTSPLY SIRONA Stock Performance

XRAY stock opened at $11.37 on Tuesday. The firm has a 50 day moving average of $11.71 and a two-hundred day moving average of $13.67. DENTSPLY SIRONA has a 12 month low of $9.85 and a 12 month high of $20.59. The company has a market capitalization of $2.27 billion, a price-to-earnings ratio of -2.57, a P/E/G ratio of 0.83 and a beta of 1.01. The company has a quick ratio of 0.99, a current ratio of 1.47 and a debt-to-equity ratio of 1.36.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.08). The business had revenue of $904.00 million for the quarter, compared to the consensus estimate of $900.33 million. DENTSPLY SIRONA had a negative net margin of 24.34% and a positive return on equity of 17.10%. The firm’s revenue for the quarter was down 4.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.50 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. As a group, equities analysts anticipate that DENTSPLY SIRONA will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 9th. Investors of record on Friday, December 26th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, December 26th. This represents a $0.64 dividend on an annualized basis and a yield of 5.6%. DENTSPLY SIRONA’s payout ratio is -14.48%.

Insiders Place Their Bets

In other DENTSPLY SIRONA news, Director Gregory T. Lucier sold 82,200 shares of the firm’s stock in a transaction on Monday, December 8th. The shares were sold at an average price of $11.14, for a total value of $915,708.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 0.52% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On DENTSPLY SIRONA

Hedge funds have recently made changes to their positions in the stock. Brooklyn Investment Group bought a new position in DENTSPLY SIRONA during the first quarter valued at about $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in shares of DENTSPLY SIRONA during the 1st quarter worth approximately $26,000. Trust Co. of Toledo NA OH bought a new stake in shares of DENTSPLY SIRONA during the second quarter valued at approximately $27,000. Parkside Financial Bank & Trust raised its stake in shares of DENTSPLY SIRONA by 620.6% in the second quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock valued at $27,000 after purchasing an additional 1,477 shares in the last quarter. Finally, Huntington National Bank raised its stake in shares of DENTSPLY SIRONA by 292.9% in the third quarter. Huntington National Bank now owns 2,786 shares of the medical instruments supplier’s stock valued at $35,000 after purchasing an additional 2,077 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.